drugset / Trial / NCT01243047
Intermittent Versus Continuous Tarceva Study
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized phase II study comprising of two treatment arms in patients who are previously untreated for metastatic or recurrent colorectal cancer.
Timeline
- Start
- 2007-09
- Primary completion
- 2012-10
- Completion
- 2012-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Erlotinib | Small molecule | 100 mg | — |
| Comparator | Erlotinib | Small molecule | 150 mg | — |
| Comparator | Capecitabine | Small molecule | — | — |
| Comparator | Oxaliplatin | Small molecule | — | — |